Perioperative continuous infusions of factor VIII versus factor IX for patients with hemophilia A or B undergoing major surgery

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies

(2022) Rebecca Kruse-Jarres et al.   Blood Advances

Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery

(2021) Ingrid Pabinger et al.   HAEMOPHILIA

Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

(2020) Rachel Rayment et al.   BRITISH JOURNAL OF HAEMATOLOGY

WFH Guidelines for the Management of Hemophilia, 3rd edition

(2020) Alok Srivastava et al.   HAEMOPHILIA

Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B

(2018) Theoni Kanellopoulou et al.   JOURNAL OF CARDIAC SURGERY

Extended Half-Life Factor VIII and Factor IX Preparations

(2018) Lukas Graf   TRANSFUSION MEDICINE AND HEMOTHERAPY

Evidence of clinically significant extravascular stores of factor IX

(2013) D. Feng et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Factor IX replacement to cover total knee replacement surgery in haemophilia B: a single-centre experience, 2000-2010

(2011) J. UPRICHARD et al.   HAEMOPHILIA

Successful treatment of acute subdural haemorrhage with continuous intravenous infusion of factor VIII in a 17 year old with haemophilia A

(2010) N. G. B. RICHARDSON et al.   HAEMOPHILIA

Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders

(2009) G. Tagariello et al.   BLOOD

Validation of a composite score for clinical severity of hemophilia

(2008) S. SCHULMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS